Home›Companies›RoosterBio

RoosterBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 25, 2024·Suggest an edit

About RoosterBio

RoosterBio is a private company based in Frederick, Maryland. It has reported $18,547,547 raised in four offerings on Form D since January 2014. Its chief executive is Timothy Kelly.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 8, 2024Mar 22, 2024amended Jul 25, 2024$11,999,990of $12.0M target8$1.4MEquity, DebtRule 506(b)Form D/A ↗1 earlier filing
Jan 27, 2017Feb 1, 2017$1,250,000fully sold1$1.2MDebt, Securities on exerciseRule 506(b)Form D ↗
Nov 23, 2016Dec 7, 2016amended Feb 27, 2017$5,197,557fully sold10$519KEquity, OptionsRule 506(b)Form D/A ↗1 earlier filing
Dec 31, 2013Jan 14, 2014$100,000of $1.0M target1$100KEquityRule 506(b)Form D ↗
Total, four offerings$18,547,547

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RoosterBio's Form D filed Jul 25, 2024.

JR
Jon Rowley
Director
MW
RP
Robert Preti
Director
RC
Rob Carlson
Director
TK
Timothy Kelly
CEO and director

Earlier filings also listed Margot Connor (president and director, last listed Feb 2017) and Uplaksh Kumar (chief operating officer and director, last listed Jan 2014).

Sources

  1. SECRoosterBio, Inc. Form D, filed Mar 22, 2024
  2. SECRoosterBio, Inc. Form D, filed Dec 7, 2016
  3. SECRoosterBio, Inc. filing history